These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21987873)

  • 1. [The era of management of hepatitis c patients].
    Moradpour D; Hadengue A
    Rev Med Suisse; 2011 Sep; 7(307):1667-8. PubMed ID: 21987873
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antiviral preparations in the therapy of chronic viral hepatitis].
    Geller LI
    Ter Arkh; 1990; 62(11):15-9. PubMed ID: 1710074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral hepatitis in 2011: a major step forward.
    Marcellin P
    Liver Int; 2011 Jan; 31 Suppl 1():1-2. PubMed ID: 21205130
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antiviral treatment of chronic hepatitis].
    Müller R
    Internist (Berl); 1984 Dec; 25(12):728-34. PubMed ID: 6083989
    [No Abstract]   [Full Text] [Related]  

  • 5. Causes of treatment failure for hepatitis C in the era of direct-acting antiviral therapy.
    Cabezas J; Llerena S; Puente Á; Fábrega E; Crespo J
    Rev Esp Enferm Dig; 2016 Jul; 108(7):421-30. PubMed ID: 26666379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatitis C: epidemiology, management and treatment].
    Poupon R
    Bull Acad Natl Med; 2005 Feb; 189(2):375-84; discussion 384-7. PubMed ID: 16114865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence and phenotypic analysis for resistance monitoring in hepatitis C virus drug development: recommendations from the HCV DRAG.
    Kwong AD; Najera I; Bechtel J; Bowden S; Fitzgibbon J; Harrington P; Kempf D; Kieffer TL; Koletzki D; Kukolj G; Lim S; Pilot-Matias T; Lin K; Mani N; Mo H; O'Rear J; Otto M; Parkin N; Pawlotsky JM; Petropoulos C; Picchio G; Ralston R; Reeves JD; Schooley RT; Seiwert S; Standring D; Stuyver L; Sullivan J; Miller V; ; ; ;
    Gastroenterology; 2011 Mar; 140(3):755-60. PubMed ID: 21255574
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiviral agents in the treatment of chronic viral hepatitis.
    Perrillo RP
    Prog Liver Dis; 1992; 10():283-309. PubMed ID: 1284255
    [No Abstract]   [Full Text] [Related]  

  • 9. Resistance to direct antiviral agents in patients with hepatitis C virus infection.
    Sarrazin C; Zeuzem S
    Gastroenterology; 2010 Feb; 138(2):447-62. PubMed ID: 20006612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiology of hepatitis C in Japan].
    Yano K; Yatsuhashi H; Yano M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):241-7. PubMed ID: 15359800
    [No Abstract]   [Full Text] [Related]  

  • 11. Towards more individualised management of hepatitis C virus patients with initially or persistently normal alanineaminotransferase levels.
    Alberti A
    J Hepatol; 2005 Feb; 42(2):266-74. PubMed ID: 15664254
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis C virus therapies.
    Smith RE
    Nat Rev Drug Discov; 2006 Sep; 5(9):715-6. PubMed ID: 17001802
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of hepatitis B and C -- current standards].
    Zeuzem S
    Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S57-9. PubMed ID: 15368169
    [No Abstract]   [Full Text] [Related]  

  • 14. New therapeutic prospects in HCV treatment.
    Almasio PL; Ingrassia D; Vergara B; Filosto S
    Expert Rev Anti Infect Ther; 2008 Dec; 6(6):775-9. PubMed ID: 19053890
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prophylaxis, Diagnosis and Therapy of Hepatitis-B-Virus-(HBV-)Infection: upgrade of the guideline, AWMF-Register 021/011].
    Cornberg M; Protzer U; Dollinger MM; Petersen J; Wedemeyer H; Berg T; Jilg W; Erhardt A; Wirth S; Schirmacher P; Fleig WE; Manns MP
    Z Gastroenterol; 2007 Jun; 45(6):525-74. PubMed ID: 17554641
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antiviral therapy of hepatitis C].
    Erhardt A; Petry W; Ebel M; Jablonowski H; Heintges T; Häussinger D
    Z Gastroenterol; 2000 Mar; 38(3):259-69. PubMed ID: 10768250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [BMS-790 052 - an oral antiviral hepatitis C antiviral in the pipeline].
    Schmitz J
    Pharm Unserer Zeit; 2011 Jan; 40(1):8-9. PubMed ID: 21194074
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial comment: triple infection with HIV and hepatitis B and C viruses--lesson in combination therapy.
    Dore GJ
    AIDS Read; 2004 Jul; 14(7):392. PubMed ID: 15282869
    [No Abstract]   [Full Text] [Related]  

  • 19. [When and how to treat hepatitis B and C?].
    Pache I; Hess J; Gonvers JJ; Moradpour D
    Rev Med Suisse; 2005 Jan; 1(3):237-41. PubMed ID: 15770818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of hepatitis C virus genotype 4.
    Abdo AA; Lee SS
    J Gastroenterol Hepatol; 2004 Nov; 19(11):1233-9. PubMed ID: 15482528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.